COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 18 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254 | -36.3% | 45,050 | -8.5% | 0.01% | -33.3% |
| Q2 2023 | $399 | -13.8% | 49,210 | -25.3% | 0.02% | -21.1% |
| Q1 2023 | $463 | -9.2% | 65,911 | +8.0% | 0.02% | -17.4% |
| Q4 2022 | $510 | -99.9% | 61,050 | -6.7% | 0.02% | +4.5% |
| Q3 2022 | $447,000 | -23.6% | 65,410 | -8.9% | 0.02% | -21.4% |
| Q2 2022 | $585,000 | -32.1% | 71,810 | -4.6% | 0.03% | -26.3% |
| Q1 2022 | $861,000 | -10.3% | 75,270 | +28.2% | 0.04% | -11.6% |
| Q4 2021 | $960,000 | -1.3% | 58,694 | +1.8% | 0.04% | -12.2% |
| Q3 2021 | $973,000 | -29.0% | 57,644 | -10.8% | 0.05% | -30.0% |
| Q2 2021 | $1,371,000 | – | 64,634 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 563,030 | $11,942,000 | 13.95% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 530,104 | $11,243,000 | 2.16% |
| FRIESS ASSOCIATES LLC | 235,092 | $4,986,000 | 1.88% |
| Weil Company, Inc. | 30,468 | $646,000 | 0.33% |
| VILLERE ST DENIS J & CO LLC | 247,250 | $5,244,000 | 0.28% |
| ACT CAPITAL MANAGEMENT, LLC | 7,500 | $160,000 | 0.08% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 64,634 | $1,371,000 | 0.07% |
| FNY Investment Advisers, LLC | 4,000 | $84,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 597 | $13,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,800 | $441,000 | 0.00% |